Eastwood Bio-Medical Canada Inc (EBM) — Cash Flow-to-Debt Ratio
Eastwood Bio-Medical Canada Inc (EBM) has a Cash Flow-to-Debt Ratio of 0.00x as of January 2026, meaning its operating cash flow of CA$-900.00 could theoretically repay 0% of its total liabilities (CA$1.90 Million) in one year. See EBM free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eastwood Bio-Medical Canada Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Eastwood Bio-Medical Canada Inc across 13 annual periods. Also explore Eastwood Bio-Medical Canada Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Eastwood Bio-Medical Canada Inc (2013–2025)
Year-by-year debt coverage analysis for Eastwood Bio-Medical Canada Inc. For market capitalisation and broader financial context, see Eastwood Bio-Medical Canada Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | CA$19.30K | CA$1.85 Million | ▲ +207.8% |
| 2024 | -0.01x | CA$-15.22K | CA$1.57 Million | ▲ +23.7% |
| 2023 | -0.01x | CA$-16.89K | CA$1.33 Million | ▼ -159.9% |
| 2022 | 0.00x | CA$-4.29K | CA$878.73K | ▲ +96.5% |
| 2021 | -0.14x | CA$-116.21K | CA$835.44K | ▲ +87.8% |
| 2020 | -1.14x | CA$-542.69K | CA$474.10K | ▼ -115.7% |
| 2019 | -0.53x | CA$-178.13K | CA$335.73K | ▲ +57.8% |
| 2018 | -1.26x | CA$-454.79K | CA$361.41K | ▲ +80.3% |
| 2017 | -6.37x | CA$-355.28K | CA$55.76K | ▲ +26.1% |
| 2016 | -8.62x | CA$-306.58K | CA$35.56K | ▼ -212.6% |
| 2015 | -2.76x | CA$-270.51K | CA$98.08K | ▼ -115.6% |
| 2014 | 17.69x | CA$1.58 Million | CA$89.19K | ▲ +27486.6% |
| 2013 | -0.06x | CA$-252.88K | CA$3.92 Million | — |